Raghu Ram Chivukula, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 12 | 2023 | 3758 | 0.690 |
Why?
|
| Mucociliary Clearance | 1 | 2020 | 80 | 0.670 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2021 | 450 | 0.580 |
Why?
|
| Critical Care | 1 | 2020 | 2696 | 0.290 |
Why?
|
| Critical Illness | 1 | 2020 | 2724 | 0.290 |
Why?
|
| Biomedical Research | 1 | 2022 | 3434 | 0.270 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 368 | 0.230 |
Why?
|
| Physicians | 1 | 2022 | 4584 | 0.230 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 3031 | 0.230 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2024 | 199 | 0.210 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1246 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2022 | 5885 | 0.200 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 161 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2024 | 705 | 0.190 |
Why?
|
| Drug Compounding | 1 | 2022 | 245 | 0.190 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2020 | 110 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2008 | 2925 | 0.170 |
Why?
|
| Ciliary Motility Disorders | 1 | 2020 | 51 | 0.170 |
Why?
|
| Microscopy, Video | 1 | 2020 | 241 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2024 | 838 | 0.160 |
Why?
|
| Lysosomes | 1 | 2024 | 921 | 0.160 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 793 | 0.150 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 233 | 0.150 |
Why?
|
| Amino Acids | 1 | 2024 | 1703 | 0.150 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 450 | 0.140 |
Why?
|
| Regeneration | 2 | 2018 | 1505 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 447 | 0.140 |
Why?
|
| Respiratory System | 1 | 2020 | 562 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 493 | 0.130 |
Why?
|
| Cilia | 1 | 2020 | 495 | 0.130 |
Why?
|
| Career Choice | 1 | 2022 | 757 | 0.130 |
Why?
|
| Schools, Medical | 1 | 2022 | 878 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 651 | 0.120 |
Why?
|
| Homozygote | 1 | 2020 | 1775 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2024 | 4243 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2014 | 28 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1721 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
| Somatomedins | 1 | 2014 | 179 | 0.110 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 258 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2014 | 276 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2010 | 2916 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2014 | 223 | 0.100 |
Why?
|
| Dependovirus | 2 | 2015 | 712 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 315 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1283 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1232 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11509 | 0.100 |
Why?
|
| Lung Transplantation | 2 | 2018 | 1307 | 0.100 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2012 | 189 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3671 | 0.090 |
Why?
|
| Isotachophoresis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Mesoderm | 1 | 2014 | 673 | 0.090 |
Why?
|
| Sinusitis | 1 | 2020 | 990 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2022 | 1959 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1856 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 1462 | 0.080 |
Why?
|
| Cyclins | 2 | 2009 | 594 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2020 | 1521 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5871 | 0.080 |
Why?
|
| Mutation | 3 | 2024 | 30002 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2142 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2015 | 1231 | 0.070 |
Why?
|
| Blood Group Incompatibility | 1 | 2008 | 135 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2015 | 3388 | 0.070 |
Why?
|
| Mice | 11 | 2024 | 81326 | 0.070 |
Why?
|
| Animals | 13 | 2024 | 168079 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2009 | 987 | 0.070 |
Why?
|
| ABO Blood-Group System | 1 | 2008 | 381 | 0.070 |
Why?
|
| Humans | 23 | 2024 | 761208 | 0.060 |
Why?
|
| ras Proteins | 1 | 2010 | 1055 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 16575 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 1932 | 0.060 |
Why?
|
| Distance Perception | 1 | 2004 | 18 | 0.060 |
Why?
|
| Illusions | 1 | 2004 | 61 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2159 | 0.060 |
Why?
|
| Growth and Development | 1 | 2023 | 46 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5366 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1749 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2009 | 1495 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 2527 | 0.050 |
Why?
|
| Gene Expression | 3 | 2022 | 7571 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9979 | 0.050 |
Why?
|
| Adult | 8 | 2024 | 221119 | 0.050 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 1591 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2024 | 23416 | 0.050 |
Why?
|
| Space Perception | 1 | 2004 | 465 | 0.050 |
Why?
|
| Cell Division | 1 | 2008 | 4451 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2012 | 2293 | 0.040 |
Why?
|
| Microtubule Proteins | 1 | 2020 | 62 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1855 | 0.040 |
Why?
|
| Saudi Arabia | 1 | 2020 | 210 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2022 | 289 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13632 | 0.040 |
Why?
|
| Liposomes | 1 | 2022 | 783 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17897 | 0.040 |
Why?
|
| Consanguinity | 1 | 2020 | 457 | 0.040 |
Why?
|
| Neoplasms | 2 | 2022 | 22140 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1129 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2020 | 12099 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 1288 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2023 | 1668 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2012 | 4309 | 0.040 |
Why?
|
| Walking | 1 | 2004 | 1194 | 0.030 |
Why?
|
| Epithelium | 1 | 2021 | 1603 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 436 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20588 | 0.030 |
Why?
|
| Time | 1 | 2018 | 545 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 1880 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 888 | 0.030 |
Why?
|
| Myocardium | 1 | 2008 | 4746 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2015 | 72 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1738 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16952 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2015 | 119 | 0.030 |
Why?
|
| United States | 1 | 2022 | 72339 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 2897 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 4242 | 0.030 |
Why?
|
| Female | 8 | 2024 | 392544 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 59221 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 88298 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9477 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 4537 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10422 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 370 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8530 | 0.020 |
Why?
|
| Child | 1 | 2020 | 80152 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 390 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1892 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 514 | 0.020 |
Why?
|
| Electrolytes | 1 | 2010 | 274 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 748 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2009 | 98 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2974 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15545 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 9566 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2008 | 207 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1057 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2008 | 199 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1720 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1963 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6124 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5828 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 1201 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 789 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5782 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3605 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2010 | 1012 | 0.010 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 799 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1695 | 0.010 |
Why?
|
| Heart Failure | 1 | 2008 | 11701 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 668 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1893 | 0.010 |
Why?
|
| Polymers | 1 | 2010 | 1617 | 0.010 |
Why?
|
| Head Movements | 1 | 2004 | 152 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2570 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3592 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 1746 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5195 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5778 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9520 | 0.010 |
Why?
|
| Male | 6 | 2020 | 360693 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12404 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3331 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 2051 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18220 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 1270 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2709 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4822 | 0.010 |
Why?
|
| Neutrophils | 1 | 2012 | 3763 | 0.010 |
Why?
|
| Zebrafish | 1 | 2010 | 3000 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4513 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2008 | 4165 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2004 | 1984 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6486 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7386 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64681 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11856 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14392 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7514 | 0.010 |
Why?
|
| Biopsy | 1 | 2008 | 6781 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2008 | 3813 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 4481 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2008 | 3258 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5869 | 0.010 |
Why?
|
| Middle Aged | 2 | 2024 | 220853 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10553 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 24021 | 0.000 |
Why?
|
| Time Factors | 1 | 2008 | 39957 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2008 | 80674 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 169288 | 0.000 |
Why?
|